Therefore, the present study investigates the circulating levels of betatrophin and the clinical parameters associated with betatrophin levels in subjects from a human cohort with or without NAFLD, which is further elucidated using in vivo and in vitro models. This evidence concerns the gene ANGPTL8 and metabolic dysfunction-associated steatotic liver disease.